In conclusion, our study expands the spectrum of clinical manifestations associated with anti-Sj/ITPR1-IgG and suggests that autoimmunity to ITPR1 may possibly be involved in the pathogenesis of peripheral neuropathy in selected patients, including in cases clinically suggestive of GBS. The gene discussed is ITPR1; the disease is Autoimmunity.